|
Market Closed -
Japan Exchange
04:30:00 11/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 6,422.00 JPY | +0.06% |
|
-5.49% | -22.09% |
| 22/08 | Alvotech Enters Licensing, Commercialization Deal for Two Biosimilars in US, Certain Asian Markets | MT |
| 18/08 | Chugai grants GSK exclusive global license for AID351 dengue antibody | AN |
| Market Cap | 10,566B 68.8B 59.28B 56.13B 50.87B 95.44B 6,573B 95.92B 667B 256B 3,344B 258B 253B | P/E 2026 * |
20.9x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 9,656B 62.87B 54.17B 51.29B 46.49B 87.22B 6,006B 87.66B 609B 234B 3,056B 236B 231B | EV / Sales 2026 * |
6.96x | EV / Sales 2027 * | 6.16x |
| Free-Float |
38.12% | Yield 2026 * |
2.12% | Yield 2027 * | 2.42% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4519 | Delayed | |
OTC Markets
| CHGCF | Delayed | |
|
Mexican S.E.
| 4519 N | End-of-day quote | |
|
Tradegate
| CUP | Real-time | |
|
Deutsche Boerse AG
| CUP | Delayed | |
|
Börse Stuttgart
| CUP | Delayed | |
|
Boerse Muenchen
| CUP | Real-time |
Last Transcript : Chugai Pharmaceutical Co., Ltd.
| 1 day | +0.06% | ||
| 1 week | -5.49% | ||
| Current month | -7.10% | ||
| 1 month | -10.61% | ||
| 3 months | -13.80% | ||
| 6 months | -31.89% | ||
| Current year | -22.09% |
| 1 week | 6,293 |  | 6,720 |
| 1 month | 6,293 | | 7,141 |
| Current year | 6,293 | | 10,700 |
| 1 year | 6,250 | | 10,700 |
| 3 years | 4,197 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/03/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 28/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 01/03/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 28/03/2024 |
| Director/Board Member | 51 | 01/03/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | -5.49% | -4.13% | +41.20% | 68.8B | |
| -0.65% | -2.93% | +47.70% | +86.17% | 994B | |
| -0.29% | -3.51% | +49.15% | +62.35% | 640B | |
| +0.83% | +0.26% | +17.76% | +72.25% | 454B | |
| -0.38% | -3.59% | +30.13% | +35.17% | 337B | |
| -0.09% | -13.54% | +13.34% | +24.95% | 261B | |
| -0.43% | -2.48% | -0.73% | +9.58% | 246B | |
| -1.34% | -13.70% | +36.53% | +44.96% | 204B | |
| -3.44% | -7.51% | -20.63% | -59.44% | 190B | |
| -0.75% | -4.82% | +25.46% | +87.14% | 178B | |
| Average | -0.65% | -5.73% | +19.46% | +40.43% | 357.36B | |
| Weighted average by Cap. | -0.49% | -4.44% | +30.28% | +54.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,388B 9.04B 7.79B 7.37B 6.68B 12.54B 864B 12.6B 87.58B 33.68B 439B 33.95B 33.2B | 1,529B 9.95B 8.58B 8.12B 7.36B 13.81B 951B 13.88B 96.45B 37.09B 484B 37.38B 36.56B |
| Net income | 506B 3.3B 2.84B 2.69B 2.44B 4.57B 315B 4.6B 31.94B 12.28B 160B 12.38B 12.11B | 583B 3.8B 3.27B 3.1B 2.81B 5.27B 363B 5.3B 36.81B 14.15B 185B 14.27B 13.95B |
| Net Debt | -910B -5.93B -5.11B -4.83B -4.38B -8.22B -566B -8.26B -57.42B -22.08B -288B -22.26B -21.77B | -1,151B -7.49B -6.46B -6.11B -5.54B -10.39B -716B -10.45B -72.6B -27.92B -364B -28.14B -27.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | JPY 6,422.00 | +0.06% | 3,008,400 |
| 10/09/26 | JPY 6,418.00 | -0.90% | 3,141,500 |
| 09/09/26 | JPY 6,476.00 | -0.86% | 2,871,600 |
| 08/09/26 | JPY 6,532.00 | -0.49% | 2,083,000 |
| 07/09/26 | JPY 6,564.00 | -3.40% | 3,444,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
